Silphium Asset Management’s Immunogen Inc IMGN Stock Holding History

Silphium Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-65,000	Closed	-$1.93M	–	55
2023 Q4	$1.93M	Buy	+65,000	New	+$1.29M	1.03%	38
2018 Q3	–	Sell	-12,547	Closed	-$122K	–	156
2018 Q2	$122K	Sell	12,547 -20,000	-61%	-$211K	0.04%	109
2018 Q1	$342K	Buy	+32,547	New	+$321K	0.19%	52

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Silphium Asset Management's IMGN Position: Q1 2024 in Review

Silphium Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 65,000 shares — an estimated $1.93M sold.

Silphium Asset Management first reported a position in IMGN in Q1 2018 and held it in 3 quarters. The position peaked at $1.93M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Silphium Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Silphium Asset Management sold 65,000 Immunogen Inc shares in Q1 2024, an estimated $1.93M.
Silphium Asset Management first reported a position in Immunogen Inc in Q1 2018 and held it in 3 quarters.
Silphium Asset Management's Immunogen Inc position peaked at $1.93M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Silphium Asset Management's 13F filing for Q1 2024, filed 30 Jan 2025.